epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Humira
    adalimumab
  • remove methocarbamol
    generic
  • remove nalbuphine
    generic
  • remove sodium bicarbonate
    generic
  • remove Yaz
    drospirenone/ ethinyl estradiol

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face methocarbamol (generic) + nalbuphine (generic)

Monitor/Modify Tx


methocarbamol + nalbuphine

monitor respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

Additional Considerations

Smiley face Smiley face adalimumab in Humira

caution advised with narrow therapeutic index drugs; chronic inflammatory conditions may alter metabolic enzyme formation; tx with immune modulators may reverse this effect, resulting in altered levels of concomitant drugs

Smiley face Smiley face nalbuphine

consider prescribing an opioid overdose reversal agent, especially with concomitant CNS depressant use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information